Filing Details
- Accession Number:
- 0001578563-24-000441
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-14 17:21:55
- Reporting Period:
- 2024-11-12
- Accepted Time:
- 2024-11-14 17:21:55
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1534120 | Avalo Therapeutics Inc. | AVTX | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1492647 | Sherie June Almenoff | C/O Avalo Therapeutics, Inc. 540 Gaither Road, Suite 400 Rockville MD 20850 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-11-12 | 500 | $12.50 | 500 | No | 4 | P | Indirect | By Meadowlark Management, LLC |
Common Stock | Acquisiton | 2024-11-13 | 500 | $13.00 | 1,000 | No | 4 | P | Indirect | By Meadowlark Management, LLC |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By Meadowlark Management, LLC |
No | 4 | P | Indirect | By Meadowlark Management, LLC |
Footnotes
- This transaction was executed in multiple trades ranging from $12.00 to $12.50. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder full information regarding the number of shares and prices at which the transactions were effected.
- The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein.